Thomas Stephan
Stock Analyst at Stifel
(1.29)
# 3,293
Out of 4,832 analysts
44
Total ratings
39.29%
Success rate
-10.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintains: Buy | $140 → $115 | $91.57 | +25.59% | 9 | May 1, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $13.24 | +111.48% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $3.31 | +20.85% | 7 | Mar 6, 2025 | |
| STAA STAAR Surgical Company | Maintains: Buy | $38 → $20 | $17.44 | +14.71% | 9 | Feb 12, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $11.55 | +55.84% | 3 | Jan 29, 2025 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.00 | +100.00% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $87.24 | +14.63% | 4 | May 15, 2024 |
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $91.57
Upside: +25.59%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $13.24
Upside: +111.48%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.31
Upside: +20.85%
STAAR Surgical Company
Feb 12, 2025
Maintains: Buy
Price Target: $38 → $20
Current: $17.44
Upside: +14.71%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $11.55
Upside: +55.84%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.00
Upside: +100.00%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $87.24
Upside: +14.63%